Official Publications of the International Cytokine & Interferon Society

Now accepting submissions!

Editor-in-Chief: Scott K Durum

Reasons to publish with us:

  • Official open access journal owned by the International Cytokine & Interferon Society
  • Encompasses all aspects of basic, clinical and translational research related to cytokines
  • Publishing definitive reviews on cytokines, interleukins, chemokines and growth factors
  • ICIS Member Discounts on article-processing charges (APC)

Submit your research to us at: signals.biomedcentral.com

Sign up for article alerts and news on the journal website!

cytokinejournalCytokine

Editor: Dr. D. Kalvakolanu
ISSN: 1043-4666 • Published Monthly
Impact Factor: 3.488
*5 year Impact Factor: 3.069
Devoted exclusively to the study of the molecular biology, genetics, biochemistry, immunology, genome-wide association studies, pathobiology, diagnostic and clinical applications of all known interleukins, hematopoietic factors, growth factors, cytotoxins,interferons, and new cytokines, and chemokines, Cytokine provides comprehensive coverage of cytokines and their mechanisms of actions, 12 times a year by publishing original high quality refereed scientific papers from prominent investigators in both the academic and industrial sectors.

Review of Interest: Cytokines in immunogenic cell death: Applications for cancer immunotherapy., Showalter A1, Limaye A1, Oyer JL1, Igarashi R1, Kittipatarin C2, Copik AJ1, Khaled AR3.

  1. Burnett School of Biomedical Science, College of Medicine, University of Central Florida, Orlando, FL 32827, United States.
  2. Office of Research and Commercialization, University of Central Florida, Orlando, FL 32826, United States.
  3. Burnett School of Biomedical Science, College of Medicine, University of Central Florida, Orlando, FL 32827, United States.

2017 Sep;97:123-132. doi: 10.1016/j.cyto.2017.05.024. Epub 2017 Jun 22.

ICIS Member Subscription rate (2017):         $179

RSS Cytokine – A list of the latest news

News: Cytokine celebrates 25th Anniversary with a special issue
October 15, 2017 at 1:00 AM

This special issue includes articles on infection and innate immunity, inflammation, Oncology, auto-immune diseases, growth factors, tissue injury-repair and mathematical modeling. Furthermore, the issue represents the scientific matter that Cytokine publishes.

Signals Newsletter – Publishing Cytokine & Interferon News since 1994

Coming soon…..ICIS Signals open access, peer reviewed journal.

Journal of Interferon & Cytokine Research

Editor-in-Chief:  Michael Gale Jr.
ISSN: 1079-9907 | Online ISSN: 1557-7465
Published Monthly | Impact Factor:* 1.774
*Five Year Impact factor is 2.348
*2018 Journal Impact Factor, Journal Citation Reports (Web of Science Group, 2019)

Meet: Editorial Board
Read/Search: Table of Contents
ICIS members:  ICIS Member Discount: All ICIS members in good standing will be eligible for a substantially discounted online subscription rate of $175 to JICR in 2019. For details and society group code, contact Joan Oefner.

The Journal of Interferon & Cytokine Research provides authoritative peer-reviewed research, analysis, and advances on the therapeutic role of cytokines and IFNs. The Journal delivers current findings on emerging topics in this niche community, including the role of IFNs in the therapy of diseases such as multiple sclerosis, the understanding of the third class of IFNs, and the identification and function of IFN-inducible genes.

Journal of Interferon & Cytokine Research coverage includes:

  • Structure/Function
  • Gene Expression
  • Antimicrobial and Antiviral Activities
  • Tumor Biology
  • Growth and Development

Journal of Interferon & Cytokine Research is under the editorial leadership of Editor-in-Chief Michael Gale Jr., Department of Immunology, University of Washington, Center for Innate Immunity and Immune Disease; and other leading investigators. View the entire Editorial Board.

RSS Journal of Interferon & Cytokine Research – Table of Contents